dihydrochalcone has been researched along with Hypertension in 1 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukamizu, A; Ichino, T; Ishida, J; Koyama, T; Matsumoto, H; Mura, E; Nakamura, K; Ohno, O; Ohno, T; Uemura, D; Yamada, K; Yamaguchi, K; Yazawa, K; Ye, M | 1 |
1 other study(ies) available for dihydrochalcone and Hypertension
| Article | Year |
|---|---|
Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzoates; Benzyl Compounds; Blood Pressure; Calcium; Cell Survival; CHO Cells; Cinnamates; Cricetinae; Cricetulus; HeLa Cells; Humans; Hypertension; Liquidambar; Magnetic Resonance Spectroscopy; Male; Mice; Receptor, Angiotensin, Type 1; Spectrometry, Mass, Electrospray Ionization | 2008 |